AOSTA. The Aosta hospital is following monoclonal antibody therapy on some patients infected with Covid-19. This is a procedure aimed at people with Sars CoV-2 who suffer from pathologies or conditions that make them particularly fragile, such as immunosuppression or complex diabetes.
For now there are three patients undergoing this therapy. The director of the USL medical disciplines department, Giulio Doveri, explains the operation in more detail. “Simplifying as much as possible, we can say that monoclonal antibodies are able to recognize the antigens of the Coronavirus, which we call” spikes “and which the virus uses to attack cells. Infusion in positive Covid patients with certain clinical conditions prevents the development of pathologies such as pneumonia at risk of very serious complications “.
“The infusions of these days – Duty resumes – place us among the first centers in Italy to use this therapy and the great teamwork and clinical, therapeutic and logistical coordination aimed at applying what can be considered, together, is evident. to the vaccine, the most effective weapon to combat Covid-19. Certainly, the vaccine remains the main solution, because it allows the immunization of people and the consequent “herd immunity”, the main objective to contain the health emergency. monoclonal antibodies make it possible to prevent pneumonia in Covid positive patients in particular clinical conditions, with a significant decrease in hospital admissions and pressure on health facilities “.
editorial board
.